Building Community Resilience Program
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIcahn School of Medicine at Mount Sinai
About this trial
Established in 2021, NYCEAL consists of approximately 40 organizational partners and 120 Community Health Workers (CHWs). Over the next four years (2024-2028), NYCEAL will work with this network to implement the following intervention: Building Community Resilience Program (BCR). To assess the impact of this intervention, an implementation research framework will be used, and pre- and post-surveys conducted, and other process evaluation measures collected. Changes in outcomes measures such as stress, resilience, overall wellbeing, and other related outcomes for participants in the BCR program will be measured for community healthcare workers and/or frontline workers that receive educational workshops.
Eligibility criteria
Qualifiers
Able to consent
Able to fill out the screening RedCap short survey
Have access to a computer or smart gadget that will allow participant to be able to join the zoom call
English speaking
Disqualifiers
Incapacitated to an extent that they are unable to comprehend a conversation or communicate effectively in a group setting
Unable to consent to be part of the study
Does not have access to a computer or smart gadget that will allow participant to be able to join the zoom call
Does not speak English
Trial design
Treatments tested in this trial
- Building Community Resilience Program (BCR)
Treatment groups
168 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov